Insmed, Inc. (INSM)
93.39
-1.67
(-1.76%)
USD |
NASDAQ |
Oct 23, 16:00
93.46
+0.08
(+0.08%)
After-Hours: 20:00
Insmed Price : 93.39 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 94.12 | 94.64 | 92.62 | 93.39 | 3.414M |
| Oct 22, 2026 | 93.50 | 95.59 | 93.33 | 95.06 | 3.100M |
| Oct 21, 2026 | 95.08 | 97.09 | 93.80 | 94.04 | 2.970M |
| Oct 20, 2026 | 95.44 | 97.20 | 94.60 | 95.67 | 2.613M |
| Oct 19, 2026 | 96.27 | 97.88 | 94.38 | 95.29 | 2.724M |
| Oct 16, 2026 | 98.70 | 99.00 | 96.05 | 96.27 | 2.397M |
| Oct 15, 2026 | 99.26 | 100.72 | 97.90 | 99.21 | 3.347M |
| Oct 14, 2026 | 97.39 | 98.00 | 95.76 | 97.79 | 2.737M |
| Oct 13, 2026 | 98.18 | 99.73 | 96.54 | 96.79 | 2.161M |
| Oct 12, 2026 | 98.82 | 100.31 | 98.33 | 98.56 | 1.696M |
| Oct 09, 2026 | 100.52 | 101.82 | 99.15 | 100.60 | 2.474M |
| Oct 08, 2026 | 100.66 | 101.06 | 96.68 | 100.48 | 5.252M |
| Oct 07, 2026 | 103.87 | 104.80 | 101.60 | 101.74 | 3.164M |
| Oct 06, 2026 | 103.97 | 107.87 | 101.32 | 105.23 | 3.686M |
| Oct 05, 2026 | 105.50 | 108.75 | 101.65 | 103.83 | 5.396M |
| Oct 02, 2026 | 107.76 | 111.54 | 105.68 | 111.12 | 4.136M |
| Oct 01, 2026 | 114.68 | 116.19 | 108.48 | 108.59 | 2.647M |
| Sep 30, 2026 | 115.65 | 116.43 | 113.60 | 114.14 | 2.870M |
| Sep 29, 2026 | 117.06 | 118.50 | 114.49 | 115.63 | 1.668M |
| Sep 28, 2026 | 116.82 | 119.32 | 116.31 | 117.67 | 1.744M |
| Sep 25, 2026 | 121.87 | 122.90 | 115.87 | 117.83 | 2.673M |
| Sep 24, 2026 | 119.26 | 121.69 | 118.38 | 121.55 | 2.234M |
| Sep 23, 2026 | 121.58 | 122.65 | 116.74 | 118.34 | 1.922M |
| Sep 22, 2026 | 121.00 | 122.48 | 119.09 | 120.82 | 2.405M |
| Sep 21, 2026 | 123.06 | 124.48 | 120.92 | 121.00 | 1.812M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 19.73 |
| Biogen, Inc. | 250.69 |
| Gilead Sciences, Inc. | 156.04 |
| United Therapeutics Corp. | 587.50 |
| Vertex Pharmaceuticals, Inc. | 523.93 |
Price Related Metrics
| PS Ratio | 17.61 |
| Price to Book Value | 26.91 |
| Earnings Yield | -4.40% |
| Market Cap | 20.39B |